Dipexium Pharmaceuticals, Inc. 4
4 · Dipexium Pharmaceuticals, Inc. · Filed Jan 21, 2016
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident, CEO, Secretary10% Owner
Transactions
- Award
Options
2016-01-19$10.16/sh+35,000$355,600→ 35,000 totalExercise: $10.16Exp: 2026-01-19→ Common stock, $0.001 par value per share (35,000 underlying)
Footnotes (1)
- [F1]Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period.